Welcome to LookChem.com Sign In|Join Free

CAS

  • or

63618-07-5

Post Buying Request

63618-07-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63618-07-5 Usage

Description

3-Azabicyclo[3.1.0] hexane-1-carboxylic acid, 3-(phenylMethyl)-, ethyl ester is a cyclopropane-based organic compound and a derivative of the amino acid proline. It is recognized for its potential biological activity and is widely utilized as a chiral building block in the synthesis of pharmaceuticals. 3-Azabicyclo[3.1.0] hexane-1-carboxylic acid, 3-(phenylMethyl)-, ethyl ester also serves as a reagent in organic synthesis, particularly for the production of drugs and other bioactive compounds.

Uses

Used in Pharmaceutical Synthesis:
3-Azabicyclo[3.1.0] hexane-1-carboxylic acid, 3-(phenylMethyl)-, ethyl ester is used as a chiral building block for the development of pharmaceuticals due to its unique structural properties and potential biological activity. It contributes to the creation of enantiomerically pure compounds, which are essential in the production of effective and safe medications.
Used in Organic Synthesis:
In the field of organic synthesis, 3-Azabicyclo[3.1.0] hexane-1-carboxylic acid, 3-(phenylMethyl)-, ethyl ester is employed as a reagent, particularly for the production of drugs and other bioactive compounds. Its cyclopropane structure and proline derivative nature make it a valuable component in the synthesis of complex organic molecules with specific biological functions.
Used in Research and Development:
3-Azabicyclo[3.1.0] hexane-1-carboxylic acid, 3-(phenylMethyl)-, ethyl ester is also utilized in research and development for the exploration of new chemical reactions and the discovery of novel bioactive compounds. Its unique properties allow scientists to investigate its potential applications in various chemical and biological processes, further expanding its use in the scientific community.

Check Digit Verification of cas no

The CAS Registry Mumber 63618-07-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,6,1 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 63618-07:
(7*6)+(6*3)+(5*6)+(4*1)+(3*8)+(2*0)+(1*7)=125
125 % 10 = 5
So 63618-07-5 is a valid CAS Registry Number.

63618-07-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-benzyl-3-azabicyclo[3.1.0]hexane-1-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63618-07-5 SDS

63618-07-5Relevant articles and documents

ALKYNYL QUINAZOLINE COMPOUNDS

-

, (2021/02/19)

The present disclosure relates to compounds of Formula (I'): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the prevention or treatment of abnormal cell growth in mammals, especially humans.

ANALOGUES OF 4H-PYRAZOLO[1,5-a] BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS

-

Paragraph 0352, (2017/02/28)

Disclosed is a series of analogues of 4H-pyrazolo[1,5-α]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.

COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING

-

, (2011/08/03)

Disclosed are muscarinic agonist compounds including oxadiazole derivatives, compositions and preparations thereof. Also disclosed are methods of synthesizing such oxadiazole compounds. Further disclosed are methods for treating a subject with said muscarinic agonists or a pharmaceutically suitable form thereof to enhance cognitive function.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 63618-07-5